Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | BLM | P54132 | 1/20 | 0.50 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.50 |
| ▸ | MMP2 | P08253 | 2/20 | 0.44 |
| ▸ | MMP9 | P14780 | 2/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 5/20 | 0.43 |
| ▸ | CA1 | P00915 | 4/20 | 0.43 |
| ▸ | FOLH1 | Q04609 | 5/20 | 0.42 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.42 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.42 |
| ▸ | BMP1 | P13497 | 1/20 | 0.42 |
| ▸ | GGH | Q92820 | 1/20 | 0.40 |
| ▸ | DPP4 | P27487 | 1/20 | 0.37 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.37 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL154381 | 1.00 | KMT2A (0.50) | KMT2AALOX15BLMPMP22MMP2 | |
| SCHEMBL8139 | 1.00 | KMT2A (0.50) | KMT2AALOX15BLMPMP22MMP2 | |
| Hydrochloric Acid SCHEMBL22978412 | 0.98 | KMT2A (0.48) | KMT2AALOX15BLMPMP22MMP2 | |
| SCHEMBL30423570 | 0.98 | KMT2A (0.48) | KMT2AALOX15BLMPMP22MMP2 | |
| Hydrochloric Acid SCHEMBL5408064 | 0.98 | KMT2A (0.48) | KMT2AALOX15BLMPMP22MMP2 | |
| Hydrochloric Acid SCHEMBL23834101 | 0.98 | KMT2A (0.48) | KMT2AALOX15BLMPMP22MMP2 | |
| SCHEMBL12611816 | 0.94 | FOLH1 (0.52) | KMT2AALOX15BLMPMP22MMP2 | |
| SCHEMBL12611809 | 0.94 | FOLH1 (0.52) | KMT2AALOX15BLMPMP22MMP2 | |
| Phosphoric Acid SCHEMBL8519191 | 0.92 | GGH (0.47) | KMT2AALOX15BLMPMP22MMP2 | |
| Phosphoric Acid SCHEMBL8519199 | 0.92 | GGH (0.47) | KMT2AALOX15BLMPMP22MMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4312 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250161408-A1 | PEPTIDIC INHIBITORS OF AMYLOID SELF- AND CROSS-ASSEMBLY | LUDWIG-MAXIMILIANS-UNIVERSITÄT MÜNCHEN (DE) | 2025-05-22 | — | — | US | claimed |
| EP-4482852-A1 | PEPTIDIC INHIBITORS OF AMYLOID SELF- AND CROSS-ASSEMBLY | Technische Universität München (DE) | 2025-01-01 | — | — | EP | claimed |
| WO-2023161211-A1 | PEPTIDIC INHIBITORS OF AMYLOID SELF- AND CROSS-ASSEMBLY | Technische Universität München (DE) | 2023-08-31 | — | — | WO | claimed |
| EP-4230645-A1 | PEPTIDIC INHIBITORS OF AMYLOID SELF- AND CROSS-ASSEMBLY | Technische Universität München (DE) | 2023-08-23 | — | — | EP | claimed |
| US-11332498-B2 | Ligands for integrin αVβ8, synthesis and uses thereof | TECHNISCHE UNIVERSITAT MUNCHEN (DE) | 2022-05-17 | — | — | US | claimed |
| CN-113769108-A | Conjugates of cysteine engineered antibodies | 伊缪诺金公司 | 2021-12-10 | — | — | CN | claimed |
| CN-110799547-A | Compounds for treating, ameliorating or preventing neurological-related disorders and uses thereof | 拜西欧斯（北京）生物技术有限公司 | 2020-02-14 | — | — | CN | claimed |
| CN-107708810-A | Conjugates of cysteine engineered antibodies | 伊缪诺金公司 | 2018-02-16 | — | — | CN | claimed |
| EP-2961435-A2 | CONJUGATES COMPRISING CELL-BINDING AGENTS AND CYTOTOXIC AGENTS | ImmunoGen, Inc. (US) | 2016-01-06 | — | — | EP | claimed |
| US-20150359904-A1 | CONJUGATES COMPRISING CELL-BINDING AGENTS AND CYTOTOXIC AGENTS | IMMUNOGEN, INC. | 2015-12-17 | — | — | US | claimed |
| WO-2001087254-A1 | USE OF ELLAGIC ACID AS ANTI-POLLUTION COSMETIC AGENT | L'OREAL (FR) | 2001-11-22 | — | — | WO | claimed |
| EP-0828480-B1 | NOVEL PHARMACEUTICAL PELLET FORMULATION | MEPHA AG (CH) | 2001-08-29 | — | — | EP | claimed |
| EP-1021161-A1 | USE OF ELLAGIC ACID AND ITS DERIVATIVES IN COSMETICS AND DERMATOLOGY | LVMH RECHERCHE (FR) | 2000-07-26 | — | — | EP | claimed |
| WO-1999016415-A1 | USE OF ELLAGIC ACID AND ITS DERIVATIVES IN COSMETICS AND DERMATOLOGY | LVMH RECHERCHE (FR) | 1999-04-08 | — | — | WO | claimed |
| EP-0833654-A1 | PEPTIDES AND COMPOUNDS THAT BIND TO THE IL-1 RECEPTOR | Affymax Technologies N.V. (GB) | 1998-04-08 | — | — | EP | claimed |
| WO-1996039165-A1 | PEPTIDES AND COMPOUNDS THAT BIND TO THE IL-1 RECEPTOR | AFFYMAX TECHNOLOGIES N.V. (GB) | 1996-12-12 | — | — | WO | claimed |
| EP-0709085-A1 | Sustained-release preparation | Takeda Chemical Industries, Ltd. (JP) | 1996-05-01 | — | — | EP | claimed |
| US-5302604-A | Squalene synthetase inhibitors, anticarcinogenic agents, zaragozic acid derivatives | MERCK & CO., INC. (US) | 1994-04-12 | — | — | US | claimed |
| US-5294627-A | Anticholesterol | MERCK & CO., INC. (US) | 1994-03-15 | — | — | US | claimed |
| WO-1993017557-A1 | CHOLESTEROL LOWERING COMPOUNDS PRODUCED BY DIRECTED BIOSYNTHESIS | MERCK & CO., INC. (US) | 1993-09-16 | — | — | WO | claimed |